First Human Trial of FTY720, a Novel Immunomodulator, in Stable Renal Transplant Patients
Klemens Budde(Charité - Universitätsmedizin Berlin), H. H. Neumayer(Medizinische Hochschule Hannover), Andrej Skerjanec, Björn Nashan(Medizinische Hochschule Hannover), Thomas U. Mayer(Max Planck Society), Robert Schmouder(Novartis (United States)), Peter W. LuCombining Diaeresiscker(Dialog Semiconductor (Germany)), Somesh Choudhury(Octane Wireless (United States)), R. Brunkhorst(Klinikum Region Hannover), Gerolf Kraus(Novartis (Switzerland))
Cited by 274
Related Papers
Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
|Pediatric Neurology|2013|1.5k
Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
|Pediatric Neurology|2013|863
Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations
|Pediatric Neurology|2021|727
Epidemiology of sepsis in Germany: results from a national prospective multicenter study
|Intensive Care Medicine|2007|623
Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease
|New England Journal of Medicine|2010|574